Mission Biocapital — 2014 Investments
2 investments dated 2014 · listed companies and verified rows first · show all
Developed site-specific protein conjugation and linker technologies; acquired by Catalent Pharma Solutions in 2014.
BiotechEmeryville, US
DAVID RABUKA(Executive Officer, Director)MICHAEL BLANK(Executive Officer)KAREN M BOEZI(Executive Officer, Director)
BoardJ GORDON FOULKES(Director)EDWARD MCCRACKEN(Director)BARRY LITTLEJOHNS(Director)
Co-investorsTakeda Ventures
BiotechBerkeley, US
Kelly Gardner(Executive Officer, Director)Elaine Heron(Director)Joshua Molho(Executive Officer, Director)
BoardDouglas Crawford(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.